Leading the Way in Life Science Technologies

GEN Exclusives

More »

November 15, Vol. 27, No. 20

  • Feature Articles

    • Eurofins MWG Consolidates Companies' Offerings
    • Sophia Fox
    • This coming January, Eurofins (wwweurofinscom) will combine the genomic products and services portfolio of its bioanalytical services company, Eurofins Medigenomix (www medigenomixcom), with that of its majority-owned oligo synthesis/sequencing company, MWG (wwwmwg-biotechcom), under a single Eurofins MWG brand... more »
    • Getting a Handle on Signal Transduction
    • Kathy Liszewski
    • Signaling networks within cells play a role in virtually every process from differentiation and proliferation to cell-cycle arrest and apoptosis Intricate cellular communication is transduced via a complex series of protein-protein interactions, post-translational modifications, and other events Deciphering the players ... more »
    • Seeking the Big Picture with Microarrays
    • Gail Dutton
    • Now that gene expression microarray experiments are routine, the challenge is to extract accurate intelligence from the data they produce The problem isn’t inaccuracies in the analysis software or methodologies, or even in the microarrays Rather, because complex biological processes ... more »
    • Innovations in Membrane Filtration Tools
    • Angelo DePalma
    • A n increasing number of pipeline drugs plus higher protein titers and cell densities are among the factors driving growth in protein purification The US market for protein separation systems was valued at approximately $3 billion in 2006, according to ... more »
    • Advancing Cancer Vaccines
    • Sue Pearson
    • The cadre of speakers extolling the virtues of therapeutic cancer vaccines at the recent “World Vaccine Congress” in Lyon, France, included Vincent Brichard, MD, PhD, vp, cancer immunotherapeutics, GlaxoSmithKline Biologicals (wwwgsk-biocom) “Many would say that therapeutic cancer vaccines have experienced ... more »
    • Army Hospital Reborn as Bioscience Park
    • Carol Potera
    • The Colorado Science+Technology Park at Fitzsimons is a poster child for how communities can transform decommissioned military installations into profit-making enterprises Originally an army hospital where soldiers had been treated since World War I, Fitzsimons Army Medical Center in Denver ... more »